U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07131007) titled 'Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics' on Aug. 11.
Brief Summary: This project is based on the in-depth analysis and integration of multi-omics data, including but not limited to genomics, transcriptomics, proteomics, and metabolomics. It aims to construct a comprehensive early-warning system for organ function damage in immune-related adverse events (irAEs) associated with immune checkpoint inhibitors (ICIs) during tumor immunotherapy. The core objective of this system is to enhance the overall safety and efficacy of tumor immunotherapy.
First, the project lev...